NL-OMON54650招募中不适用
Genetic Determinants of the Outcome of Immune Tolerance Induction therapy in patients with severe haemophilia A and inhibitors - GO ITI Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 至 99（—）
入选标准
- •1. Severe haemophilia A, defined as a baseline FVIII activity of <0.01 IU mL-1.
- •2. A current or a history of inhibitor development.
- •3. Received or is currently receiving immune tolerance induction therapy of any
- •4. Written informed consent.
排除标准
- •Refused informed consent
研究者
相似试验
已完成
不适用
Genetic polymorphisms and immunologic profiles in arteriogenesisObstructive coronary artery disease and collateral artery growth10011082NL-OMON44569VU University Medical Center50
已完成
不适用
Associations between genetic variation and immune response in infants with respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI)RSV bronchiolitis1004743810024970lower respiratory tract infectionNL-OMON31227aboratorium voor Gezondheidsbeschermingsonderzoek250
尚未招募
不适用
A study on primary immunodeficiencies in Indian Population to understand the geneticsCTRI/2020/08/027311Indian Council of Medical Research
已完成
不适用
Genetic and immunological variability in Autoimmune lymphoproliferative Syndrome. A Patient Register.Autoimmune lymphoproliferative syndrome (ALPS)DRKS00000298Centrum für Chronische ImmmundefizienzUniversitätsklinikum Freiburg311
招募中
不适用
Genetic factors, serum markers, and the risk of TIA and stroke. Collection and storage of peripheral blood samples for neurovascular research in the Rotterdam Stroke Databankcerebral infarct / hemorrhage10007963StrokeNL-OMON30779Erasmus MC, Universitair Medisch Centrum Rotterdam1,000